Short Interest in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Grows By 186.0%

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) was the target of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 12,300 shares, an increase of 186.0% from the September 15th total of 4,300 shares. Approximately 0.3% of the company’s shares are short sold. Based on an average trading volume of 3,900 shares, the short-interest ratio is currently 3.2 days.

Institutional Trading of Cryo-Cell International

An institutional investor recently bought a new position in Cryo-Cell International stock. Rowlandmiller & PARTNERS.ADV purchased a new position in shares of Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 14,433 shares of the company’s stock, valued at approximately $108,000. Rowlandmiller & PARTNERS.ADV owned about 0.17% of Cryo-Cell International as of its most recent SEC filing. 10.44% of the stock is owned by institutional investors and hedge funds.

Cryo-Cell International Trading Down 3.4 %

Shares of CCEL stock traded down $0.22 on Friday, hitting $6.26. The stock had a trading volume of 877 shares, compared to its average volume of 7,570. Cryo-Cell International has a 1 year low of $3.67 and a 1 year high of $9.50. The company has a market capitalization of $50.46 million, a PE ratio of -5.64 and a beta of 0.45.

Cryo-Cell International (NYSEAMERICAN:CCEL) last announced its earnings results on Monday, July 15th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.04. Cryo-Cell International had a negative net margin of 29.38% and a negative return on equity of 49.94%. The firm had revenue of $8.04 million for the quarter.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.